BIOCANCELL THERAPEUTICS INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/7e758408-439e-4a2e-ba26-03627e23399d/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2011 | $-27.7M | 2004-10-01 – 2012-03-31 | evidence 0001178913-12-001404 |
| FY 2010 | $-2.2M | 2010-01-01 – 2010-12-31 | evidence 0001178913-12-000905 |
| FY 2009 | $-6.8M | 2009-01-01 – 2009-12-31 | evidence 0001178913-12-000905 |
| FY 2008 | $-2.9M | 2008-01-01 – 2008-12-31 | evidence 0001178913-12-000905 |
| FY 2007 | $-3.9M | 2007-01-01 – 2007-12-31 | evidence 0001178913-12-000905 |
| FY 2006 | $-2.3M | 2006-01-01 – 2006-12-31 | evidence 0001178913-12-000905 |
| FY 2005 | $-834.0k | 2005-01-01 – 2005-12-31 | evidence 0001178913-12-000905 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).